Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma
The Journal of Dermatology Dec 07, 2018
Suzuki H, et al. - Researchers examined the serum amyloid A (SAA) levels in the blood of patients with atopic dermatitis (AD) and cutaneous T-cell lymphoma (CTCL). Findings suggested the SAA levels in blood and the number of white blood cells in peripheral blood and serum sIL-2R levels in CTCL patients to be significantly correlated. Increased levels of SAA were demonstrated by the AD patients without topical steroid treatment and CTCL patients without narrowband ultraviolet B therapy, which suggested that SAA levels may easily fluctuate with treatment. In development of AD and CTCL, a possible contribution of SAA is implied by the findings.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries